vs
Side-by-side financial comparison of Mobileye Global Inc. (MBLY) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $558.0M, roughly 2.0× Mobileye Global Inc.). On growth, Mobileye Global Inc. posted the faster year-over-year revenue change (27.4% vs -2.5%). Over the past eight quarters, Mobileye Global Inc.'s revenue compounded faster (12.7% CAGR vs 1.3%).
Mobileye Global Inc. is a United States-domiciled, Israel-headquartered autonomous driving company. It is developing self-driving technologies and advanced driver-assistance systems (ADAS) including cameras, computer chips, and software. Mobileye was acquired by Intel in 2017 and went public again in 2022.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
MBLY vs PRGO — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $558.0M | $1.1B |
| Net Profit | — | $-1.4B |
| Gross Margin | 49.3% | 32.6% |
| Operating Margin | -647.5% | -116.0% |
| Net Margin | — | -127.8% |
| Revenue YoY | 27.4% | -2.5% |
| Net Profit YoY | — | -3093.9% |
| EPS (diluted) | — | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $558.0M | — | ||
| Q4 25 | $446.0M | $1.1B | ||
| Q3 25 | $504.0M | $1.0B | ||
| Q2 25 | $506.0M | $1.1B | ||
| Q1 25 | $438.0M | $1.0B | ||
| Q4 24 | $490.0M | $1.1B | ||
| Q3 24 | $486.0M | $1.1B | ||
| Q2 24 | $439.0M | $1.1B |
| Q1 26 | — | — | ||
| Q4 25 | $-127.0M | $-1.4B | ||
| Q3 25 | $-96.0M | $7.5M | ||
| Q2 25 | $-67.0M | $-8.4M | ||
| Q1 25 | $-102.0M | $-6.4M | ||
| Q4 24 | $-71.0M | $-44.4M | ||
| Q3 24 | $-2.7B | $-21.0M | ||
| Q2 24 | $-86.0M | $-108.4M |
| Q1 26 | 49.3% | — | ||
| Q4 25 | 45.3% | 32.6% | ||
| Q3 25 | 48.2% | 36.1% | ||
| Q2 25 | 49.8% | 34.4% | ||
| Q1 25 | 47.3% | 37.6% | ||
| Q4 24 | 49.2% | 33.9% | ||
| Q3 24 | 48.8% | 37.2% | ||
| Q2 24 | 47.6% | 37.0% |
| Q1 26 | -647.5% | — | ||
| Q4 25 | -31.4% | -116.0% | ||
| Q3 25 | -21.6% | 7.0% | ||
| Q2 25 | -14.6% | 4.3% | ||
| Q1 25 | -26.7% | 4.5% | ||
| Q4 24 | -17.6% | 10.0% | ||
| Q3 24 | -577.6% | 7.4% | ||
| Q2 24 | -21.4% | -2.5% |
| Q1 26 | — | — | ||
| Q4 25 | -28.5% | -127.8% | ||
| Q3 25 | -19.0% | 0.7% | ||
| Q2 25 | -13.2% | -0.8% | ||
| Q1 25 | -23.3% | -0.6% | ||
| Q4 24 | -14.5% | -3.9% | ||
| Q3 24 | -558.6% | -1.9% | ||
| Q2 24 | -19.6% | -10.2% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.15 | $-10.23 | ||
| Q3 25 | $-0.12 | $0.05 | ||
| Q2 25 | $-0.08 | $-0.06 | ||
| Q1 25 | $-0.13 | $-0.05 | ||
| Q4 24 | $-0.09 | $-0.32 | ||
| Q3 24 | $-3.35 | $-0.15 | ||
| Q2 24 | $-0.11 | $-0.79 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.2B | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $8.2B | $2.9B |
| Total Assets | $8.7B | $8.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.7B | $432.1M | ||
| Q2 25 | $1.7B | $454.2M | ||
| Q1 25 | $1.5B | $409.9M | ||
| Q4 24 | $1.4B | $558.8M | ||
| Q3 24 | $1.3B | $1.5B | ||
| Q2 24 | $1.2B | $542.8M |
| Q1 26 | $8.2B | — | ||
| Q4 25 | $11.9B | $2.9B | ||
| Q3 25 | $11.9B | $4.4B | ||
| Q2 25 | $12.1B | $4.5B | ||
| Q1 25 | $12.0B | $4.4B | ||
| Q4 24 | $12.1B | $4.3B | ||
| Q3 24 | $12.1B | $4.6B | ||
| Q2 24 | $14.7B | $4.5B |
| Q1 26 | $8.7B | — | ||
| Q4 25 | $12.5B | $8.5B | ||
| Q3 25 | $12.5B | $10.1B | ||
| Q2 25 | $12.6B | $10.1B | ||
| Q1 25 | $12.5B | $9.8B | ||
| Q4 24 | $12.6B | $9.6B | ||
| Q3 24 | $12.6B | $11.2B | ||
| Q2 24 | $15.3B | $10.4B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $75.0M | $175.4M |
| Free Cash FlowOCF − Capex | — | $148.6M |
| FCF MarginFCF / Revenue | — | 13.4% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $75.0M | — | ||
| Q4 25 | $113.0M | $175.4M | ||
| Q3 25 | $167.0M | $51.7M | ||
| Q2 25 | $213.0M | $75.9M | ||
| Q1 25 | $109.0M | $-64.5M | ||
| Q4 24 | $204.0M | $312.6M | ||
| Q3 24 | $126.0M | $42.2M | ||
| Q2 24 | $30.0M | $9.5M |
| Q1 26 | — | — | ||
| Q4 25 | $86.0M | $148.6M | ||
| Q3 25 | $143.0M | $29.8M | ||
| Q2 25 | $199.0M | $56.7M | ||
| Q1 25 | $95.0M | $-90.0M | ||
| Q4 24 | $191.0M | $274.9M | ||
| Q3 24 | $104.0M | $15.1M | ||
| Q2 24 | $6.0M | $-18.9M |
| Q1 26 | — | — | ||
| Q4 25 | 19.3% | 13.4% | ||
| Q3 25 | 28.4% | 2.9% | ||
| Q2 25 | 39.3% | 5.4% | ||
| Q1 25 | 21.7% | -8.6% | ||
| Q4 24 | 39.0% | 24.2% | ||
| Q3 24 | 21.4% | 1.4% | ||
| Q2 24 | 1.4% | -1.8% |
| Q1 26 | — | — | ||
| Q4 25 | 6.1% | 2.4% | ||
| Q3 25 | 4.8% | 2.1% | ||
| Q2 25 | 2.8% | 1.8% | ||
| Q1 25 | 3.2% | 2.4% | ||
| Q4 24 | 2.7% | 3.3% | ||
| Q3 24 | 4.5% | 2.5% | ||
| Q2 24 | 5.5% | 2.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 6.89× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MBLY
Segment breakdown not available.
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
